Chemomab Therapeutics Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CMMB research report →
About the company
Chemomab Therapeutics Ltd. operates as a clinical-stage biotechnology firm, dedicated to identifying and advancing novel treatments for inflammatory and fibrotic conditions. Its leading experimental drug candidate, CM-101, is a humanized monoclonal antibody specifically engineered to impede the core function of soluble chemokine CCL24.
- CEO
- Adi Mor George
- IPO
- 2019
- Employees
- 20
- HQ
- Tel Aviv, IL
Price Chart
- Market Cap
- $13.97M
- P/E
- -2.06
- P/S
- 0.00
- P/B
- 1.69
- EV/EBITDA
- -1.02
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -67.85%
- ROIC
- -74.26%
- Revenue
- $0 · 0.00%
- Net Income
- $-8,995,000 · 35.50%
- EPS
- $-1.42 · 54.51%
- Op Income
- $-9,567,000
- FCF YoY
- 27.41%
- 52W High
- $4.92
- 52W Low
- $1.35
- 50D MA
- $1.70
- 200D MA
- $2.06
- Beta
- 0.64
- Avg Volume
- 65.36K
Get TickerSpark's AI analysis on CMMB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 1, 26 | Melincoff Gwen A | other | 8,621 |
| May 29, 26 | Mor George Adi | buy | 4,926 |
| May 29, 26 | Mor George Adi | buy | 4,878 |
| May 29, 26 | Mor George Adi | other | 31,712 |
| May 29, 26 | Mor George Adi | other | 18,750 |
| Mar 18, 26 | Mor George Adi | other | 0 |
| Mar 18, 26 | Mor George Adi | other | 0 |
| Mar 18, 26 | Mor George Adi | other | 0 |
| Mar 18, 26 | Mor George Adi | other | 0 |
| Mar 18, 26 | Mor George Adi | other | 32,925 |
Our CMMB coverage
Recent articles, reports, and earnings notes.
No research on CMMB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CMMB report →Similar companies
Peers in the same neighborhood.